ArticleJournal of clinical medicine2022

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

Nuria Muñoz-Rivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.